Bakyt Keneshbekovna Orosalieva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Bakyt Keneshbekovna Orosalieva has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Asel Sansyzbaevna Imankulova
P. Lumumbi Peoples’ Friendship University of Russia Ministry of Education and Science of Russia; Salymbekov University
2 shared publications - A. A. Zurdinova
Kyrgyz-Russian Slavic University named after the first President of the Russian Federation B.N. Yeltsin
1 shared publication Ainura Sharaeva
1 shared publicationElena Vladimirovna Khegai
Kyrgyz State Medical Academy named after I K Akhunbaeva
1 shared publication- Gulmira Djumalieva
Кыргызская государственная медицинская академия им. И.К. Ахунбаева, Бишкек, Кыргызская Республика
1 shared publication Nargiza Abdibalievna Subanova
Kyrgyz State Medical Academy named after I K Akhunbaeva
1 shared publication
Latest Publications
- Open Access
- 1 May 2022
- Published by Indian Association of Biomedical Scientists in Biomedicine
- Vol. 42 (2) , 307-313
Evaluation of hospital-level antibiotic use in Kyrgyzstan between 2016 and 2019 based on the World Health Organization AWaRe classification
Introduction and Aim: One of the main goals of the World Health Organization (WHO) global action plan to combat Antimicrobial Resistance is to study the tendency of antimicrobial consumption for systemic use to improve how antimicrobial medications are prescribed and utilized. The objective of the study was to evaluate antibiotic use based on the WHO Access, Watch, Reserve (AWaRe) classification and analyse antimicrobial consumption using Defined Daily Doses in a multidisciplinary hospital in Bishkek, Kyrgyzstan, between 2016 and 2019. Materials and Methods: A retrospective longitudinal analysis of antimicrobial consumption data from a multidisciplinary hospital in Bishkek, Kyrgyzstan, was completed between 2016 and 2019. Information on the structure and volume of antimicrobial consumption, and the number of bed days, was obtained from the internal database and official annual reports of the multidisciplinary hospital. Results: The consumption of levofloxacin increased by 3.935 Defined Daily Doses per 100 Bed-Days (DDD/100BD) (5.6 times) and that of moxifloxacin by 450 DDD/100BD (10.1 times), compared to that in 2016. Notably, the analysis of data on DDD/100BD consumption based on antimicrobial groups identified the most frequently used medications as stationary data points and identified the top-assigned antimicrobials from different groups, which increased in consumption over time. Conclusion: The rapid growth in the use of antibiotics from the Watch class, particularly in low- and middle-income countries, reflects the challenges associated with the rational use of antibiotics. The AWaRe system is an important indicator of efforts to combat Antimicrobial Resistance and ensure equal access to effective antibiotics worldwide.
- 1 May 2022
- Published by Indian Association of Biomedical Scientists in Biomedicine
- Vol. 42 (2) , 307-313
Open AccessEvaluation of hospital-level antibiotic use in Kyrgyzstan between 2016 and 2019 based on the World Health Organization AWaRe classification
Introduction and Aim: One of the main goals of the World Health Organization (WHO) global action plan to combat Antimicrobial Resistance is to study the tendency of antimicrobial consumption for systemic use to improve how antimicrobial medications are prescribed and utilized. The objective of the study was to evaluate antibiotic use based on the WHO Access, Watch, Reserve (AWaRe) classification and analyse antimicrobial consumption using Defined Daily Doses in a multidisciplinary hospital in Bishkek, Kyrgyzstan, between 2016 and 2019. Materials and Methods: A retrospective longitudinal analysis of antimicrobial consumption data from a multidisciplinary hospital in Bishkek, Kyrgyzstan, was completed between 2016 and 2019. Information on the structure and volume of antimicrobial consumption, and the number of bed days, was obtained from the internal database and official annual reports of the multidisciplinary hospital. Results: The consumption of levofloxacin increased by 3.935 Defined Daily Doses per 100 Bed-Days (DDD/100BD) (5.6 times) and that of moxifloxacin by 450 DDD/100BD (10.1 times), compared to that in 2016. Notably, the analysis of data on DDD/100BD consumption based on antimicrobial groups identified the most frequently used medications as stationary data points and identified the top-assigned antimicrobials from different groups, which increased in consumption over time. Conclusion: The rapid growth in the use of antibiotics from the Watch class, particularly in low- and middle-income countries, reflects the challenges associated with the rational use of antibiotics. The AWaRe system is an important indicator of efforts to combat Antimicrobial Resistance and ensure equal access to effective antibiotics worldwide.
- 1 January 2021
- Published by Establishment "RSPJHCK" in Scientific and Practical Journal Healthcare of Kyrgyzstan
- No. 2,p. 31-39
Analysis of the antibiotic resistance among women with purulent septic complications after childbirth
- 1 January 2021
- Published by Establishment "RSPJHCK" in Scientific and Practical Journal Healthcare of Kyrgyzstan
- No. 2,p. 31-39
Analysis of the antibiotic resistance among women with purulent septic complications after childbirth